跳至主要内容
临床试验/JPRN-UMIN000007835
JPRN-UMIN000007835已完成未知

Study of the Effects of eicosapentaenoic acid on diabetic atherosclerotic lesion - E-EPADALE

Osaka University Graduate School0 个研究点目标入组 44 人开始时间: 2012年4月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients meeting one of the following conditions will be excluded: 1) type 1 and secondary diabetes, 2) severe infectious disease, before or after surgery, and severe trauma, 3) events of myocardial infarction, angina pectoris, cerebral stroke, and cerebral infarction, 4) moderate or severe renal dysfunction (serum creatinine (mg/dL): male, 1.4<; female, 1.2<), 5) severe liver dysfunction (AST: 100 IU/l or higher), 6) moderate or severe heart failure) (NYHA/New York Heart Association stage III or severer), 7) under treatment with an EPA preparation at the time of study initiation, 8) pregnant, lactating, and possibly pregnant women and those planning to become pregnant, 9) patients with bleeding (hemophilia, gastrointestinal ulceration, urinary tract bleeding, hemoptysis, vitreous hemorrhage, etc.), 10) past medical history of hypersensitivity to investigational drugs, 11) judged as ineligible by clinical investigators.

研究者

发起方
Osaka University Graduate School

相似试验

Study of the Effects of eicosapentaenoic acid on... | 临床试验